Therefore, we investigated how O-GlcNAcylation of XRCC4 affects cancer cell responses to DNA DSBs induced by bleomycin, a radiomimetic and chemotherapeutic drug commonly used in DNA repair studies and a DNA damage-inducing agent [43, 52, 53]. Here, XRCC4 is linked to cancer.